Core Viewpoint - The company has received a medical device registration certificate from the National Medical Products Administration of China for its recombinant type I α1 collagen and sodium hyaluronate composite solution, marking a significant milestone in its product development and market expansion [1] Product Development - The product is the world's first recombinant collagen and sodium hyaluronate composite solution approved for improving cheek smoothness, showcasing the company's innovative capabilities [1] - This approval follows the successful registration of the recombinant type I α1 collagen freeze-dried fiber, further expanding the company's product matrix [1] Market Strategy - The company aims to steadily promote the product's market launch and distribution, leveraging a diverse product portfolio, comprehensive channel network, and refined brand management [1] - The introduction of this product is expected to inject new growth momentum into the company's business development in the skin rejuvenation sector [1]

Core Viewpoint - The company has received a medical device registration certificate for its recombinant type I α1 collagen freeze-dried fiber product, marking a significant advancement in its product offerings and potential market opportunities in the skin rejuvenation sector [1] Group 1: Product Approval - The product is the first recombinant type I natural sequence collagen injectable approved in China, showcasing the company's technological research and development capabilities [1] - The approval was granted through a joint review of device and drug assessments, highlighting the regulatory efficiency [1] Group 2: Market Opportunities - The new product will enhance the company's product portfolio and provide new opportunities for business development in the skin rejuvenation market [1] - The company plans to gradually launch and promote the product in accordance with its business strategy, aiming to offer a diverse experience to consumers [1] Group 3: Competitive Position - The approval reinforces the company's leading position in the health and beauty sector, allowing it to strengthen its existing products, brands, and channels [1]